Southampton is part of the national effort to prevent, diagnose and treat COVID-19 – see a list of our COVID-19 studies.
As we continue those efforts we are restarting and reopening other research studies. This is to ensure we continue to advance care and treatments for our patients across a range of conditions throughout the pandemic.
If you were taking part in a study that was paused, your study team may be in touch to discuss continuing your participation. Please bear with us as we work to open a large number of studies, with those with significant implications for participant’s standard of care our priority.
Our clinical research is advancing the latest discoveries into clinic and community,driving better healthcare and changing people’s lives.
Exceptional clinical research
We have an excellent track record in clinical research, with particular strengths in nutrition, respiratory cancer and musculoskeletal research. Find out more in our Research areas.
See our Impact case studies for examples of how our research is changing healthcare for the better.
Embedded at the heart of on of the UK's largest acute teaching hospitals, our translational research facilities are where we take discoveries and new treatments into the clinic.You can find out more in our Facilities section, or link direct to specific facilities below:
The National Institute for Health Research (NIHR) has invested over £27m in our clinical research facilities and resources, including our centre for advancing health through nutrition and respiratory research.
These centres of excellence, alongside those in cancer and musculoskeletal research, are centred on our NIHR Southampton Clinical Research Facility. One of the UK's prime sites for early phase trials, it has a long track record in delivering clinical trials on time, on target to the highest safety and quality standards.